Journals / Acta Medica Alanya / 2019 / Cilt: 3 - Sayı: 3

The Relationship Between Blood Neutrophil to Lymphocyte Ratio and Tumor Size, Tumor Number, Macrovascular Invasion in Patients with Hepatocellular Carcinoma

Hepatosellüler Karsinomalı Hastalarda Kan Nötrofil Lenfosit Oranı ile Tümör Boyutu, Tümör Sayısı ve Makrovasküler İnvazyon Arasındaki İlişki

Pages
207–212
Publication Date
2022-09-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There were significant association between neutrophil tolym-phocyte ratio > 3.17 and macrovascular invasion, the tumor number> 3, thetumor size> 5 cm, Child-Turcot-Pugh score, Model for End-stage Liver DiseaseSodium score, C-reactive protein and blood sodium level (p: 0.005, p: 0.009, p 3.17 was an independent predictor oftumor size> 5 cm and hyponatremia in patients with hepatocellular carcinoma (p:0.010, p: 0.012, respectively).Conclusions: The value of blood neutrophil to lymphocyte ratio at the time of diagnosis in patients with hepatocellular carcinoma was a good predictor of tumor sizeand grade of disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: We aimed to show the relationship between blood neutrophil to lymphocyteratio that is systemic inflammatory marker and tumor s ize, tumor number, macrovascular invasion at the time of diagnosis in patients with hepatocellular carcinoma.Methods: A total 48 patients diagnosed with hepatocellular carcinoma were includedin our study.
📊
Key Findings & Data:The patients were divided into two groups according to themedian neutrophil to lymphocyte ratio.Results: A total of 48 patients (11 female, 37 male) were included in our study.The mean age of the patients were 67.18±9.51 years-old.
💡
Conclusion & Impact:There were significant association between neutrophil tolym-phocyte ratio > 3.17 and macrovascular invasion, the tumor number> 3, thetumor size> 5 cm, Child-Turcot-Pugh score, Model for End-stage Liver DiseaseSodium score, C-reactive protein and blood sodium level (p: 0.005, p: 0.009, p 3.17 was an independent predictor oftumor size> 5 cm and hyponatremia in patients with hepatocellular carcinoma (p:0.010, p: 0.012, respectively).Conclusions: The value of blood neutrophil to lymphocyte ratio at the time of diagnosis in patients with hepatocellular carcinoma was a good predictor of tumor sizeand grade of disease.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: We aimed to show the relationship between blood neutrophil to lymphocyteratio that is systemic inflammatory marker and tumor s ize, tumor number, macrovascular invasion at the time of diagnosis in patients with hepatocellular carcinoma.Methods: A total 48 patients diagnosed with hepatocellular carcinoma were includedin our study. The patients were divided into two groups according to themedian neutrophil to lymphocyte ratio.Results: A total of 48 patients (11 female, 37 male) were included in our study.The mean age of the patients were 67.18±9.51 years-old. The median neutrophil tolym-phocyte ratio was 3.17. There were significant association between neutrophil tolym-phocyte ratio > 3.17 and macrovascular invasion, the tumor number> 3, thetumor size> 5 cm, Child-Turcot-Pugh score, Model for End-stage Liver DiseaseSodium score, C-reactive protein and blood sodium level (p: 0.005, p: 0.009, p 3.17 was an independent predictor oftumor size> 5 cm and hyponatremia in patients with hepatocellular carcinoma (p:0.010, p: 0.012, respectively).Conclusions: The value of blood neutrophil to lymphocyte ratio at the time of diagnosis in patients with hepatocellular carcinoma was a good predictor of tumor sizeand grade of disease.

Özet

Amaç: Hepatosellüler Karsinomu olan hastalarda tanı anındaki tümör boyutu, tümör sayısı ve makrovasküler invazyon ile kan nötrofil lenfosit oranı arasındaki ilişkiyi göstermeyi amaçladık. Hastalar ve Method: Çalışmaya toplam 48 hepatosellüler karsinomalı hasta dahil edildi. Hastalar ortalama nötrofil lenfosit oranına göre ikiye bölündü. Bulgular: Toplam 48 hastanın 11’i kadın, 37’si erkek idi. Hastaların ortalama yaşı 67,18±9,51 idi. Ortalama nötrofil lenfosit oranı 3,17 idi. Nötrofil lenfosit oranı (NLR)>3,17 olan hastalarda makrovasküler invazyon, tümör sayısının>3, tümör boyutu>5 cm, Child-Turcot-Pugh skor, Model for End-stage Liver Disease- Sodyum skor, C-reaktif protein and kan sodyum seviyesi ile arasında istatistiksel olarak anlamlı birliktelik izlendi (p: 0.005, p: 0.009, p 3.17 olması tumor boyutu> 5 cm and hiponatreminin bağımsız bir belirteci olduğunu gösterdi (p: 0.010, p: 0.012, sırasıyla). Sonuç: Hepatosellüler karsinomalı hastalarda tanı anındaki kan nötrofil lenfosit oranının değeri, tümör boyutunun ve hastalık evresinin iyi bir belirtecidir.

🔖

Cite This Article

ÇAKIR, Ö. Ö. (2022). The Relationship Between Blood Neutrophil to Lymphocyte Ratio and Tumor Size, Tumor Number, Macrovascular Invasion in Patients with Hepatocellular Carcinoma. Acta Medica Alanya, Cilt: 3 - Sayı: 3, 207–212. https://ajindex.com/articles/425878

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Bosch FX, Ribes J, Cleries R, Diaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis. 2005;9:191-211. doi: 10.1016/j.cld.2004.12.009
  2. Forner A, Reig ME, de Lope CR, Bruix J. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis. 2010;30:61–74. doi: 10.1055/s-0030-1247133
  3. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatol. 2001;33:1394-403. doi:10.1053/jhep.2001.24563
  4. Tsochatzis EA, Germani G, Burroughs AK. Transarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment. Semin Oncol. 2010;37:89-93. doi: 10.1053/j.seminoncol.2010.03.007
  5. Duvoux C, Roudot-Thoraval F, Decaens T, Pessione F, Badran H, Piardi T, et al. Liver transplantation for hepatocellular carcinoma: a model including alpha-fetoprotein improves the performance of Milan criteria. Gastroenterol. 2012;143:986- 94e3. doi: 10.1053/j.gastro.2012.05.052
  6. Koh CH, Bhoo-Pathy N, Ng KL, Jabir RS, Tan GH, See MH, et al. Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer. Brit J Cancer. 2015;113:150-8. doi: 10.1038/bjc.2015.183
  7. Aliustaoglu M, Bilici A, Ustaalioglu BB, Konya V, Gucun M, Seker M, et al. The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment. Med Oncol. 2010;27:1060-5. doi: 10.1007/s12032-009- 9335-4
  8. Xu ZG, Ye CJ, Liu LX, Wu G, Zhao ZX, Wang YZ, et al. The pretransplant neutrophil-lymphocyte ratio as a new prognostic predictor after liver transplantation for hepatocellular cancer: a systematic review and meta-analysis. Biomark Med. 2018;12(2):189-99. doi: 10.2217/bmm-2017-0307
  9. Liu C, Jia BS, Zou BW, Du H, Yan LN, Yang JY, et al. Neutrophil-to-lymphocyte and aspartate-to-alanine aminotransferase ratios predict hepatocellular carcinoma prognosis after transarterial embolization. Medicine (Baltimore). 2017;96(45):e8512. doi: 10.1097/MD.0000000000008512
  10. Jordi Bruix, Morris Sherman. Management of Hepatocellular Carcinoma: An Update. Hepatology. 2011;53(3):1020-2. doi: 10.1002/hep.24199
  11. Freeman RB Jr, Wiesner RH, Harper A, McDiarmid SV, Lake J, Edwards E. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002;8